NEW YORK (GenomeWeb News) – The Two Blades Foundation today said it has completed a non-exclusive licensing agreement with KWS SAAT covering Two Blades' Transcription Activator Like effector code technology for genome engineering in certain crops.

The technology is for making specific changes in genomes based on novel sequence-specific DNA-binding proteins. TAL effector proteins can be designed to recognize almost any DNA sequence of interest and specific locations in the genome can be targeted for gene replacement and gene function modulation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.